SG11202102818YA - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents
Ophthalmic compositions for treatment of ocular surface damage and symptoms of drynessInfo
- Publication number
- SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA
- Authority
- SG
- Singapore
- Prior art keywords
- dryness
- symptoms
- treatment
- surface damage
- ocular surface
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18196126 | 2018-09-22 | ||
| EP18198440 | 2018-10-03 | ||
| EP18202041 | 2018-10-23 | ||
| PCT/EP2019/075406 WO2020058504A1 (en) | 2018-09-22 | 2019-09-20 | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102818YA true SG11202102818YA (en) | 2021-04-29 |
Family
ID=68240699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102818YA SG11202102818YA (en) | 2018-09-22 | 2019-09-20 | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210346313A1 (en) |
| EP (1) | EP3852734A1 (en) |
| JP (1) | JP2022500461A (en) |
| KR (1) | KR20210080388A (en) |
| CN (1) | CN112739335A (en) |
| AU (1) | AU2019342426A1 (en) |
| CA (1) | CA3111873A1 (en) |
| IL (1) | IL281516A (en) |
| PH (1) | PH12021550621A1 (en) |
| SG (1) | SG11202102818YA (en) |
| WO (1) | WO2020058504A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2743502T3 (en) | 2015-09-30 | 2020-02-19 | Novaliq Gmbh | Semi-fluorinated compounds and their compositions |
| PL3442480T3 (en) | 2016-06-23 | 2020-04-30 | Novaliq Gmbh | Topical administration method |
| CN116172987A (en) | 2016-09-22 | 2023-05-30 | 诺瓦利克有限责任公司 | Pharmaceutical composition for treating blepharitis |
| ES2965677T3 (en) | 2016-09-23 | 2024-04-16 | Novaliq Gmbh | Ophthalmic compositions comprising cyclosporine |
| PL3612228T3 (en) | 2017-04-21 | 2024-04-08 | Dermaliq Therapeutics, Inc. | Iodine compositions |
| WO2019063551A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| CN112135603B (en) | 2018-03-02 | 2024-04-16 | 诺瓦利克有限责任公司 | Pharmaceutical composition comprising nebivolol |
| US12226422B2 (en) | 2018-04-27 | 2025-02-18 | Novaliq Gmbh | Ophthalmic compositions comprising tafluprost for the treatment of glaucoma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19938668B4 (en) | 1999-08-14 | 2006-01-26 | Bausch & Lomb Inc. | Artificial tears |
| EP2335735A1 (en) | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| PL3181119T3 (en) * | 2012-09-12 | 2020-01-31 | Novaliq Gmbh | Semifluorinated alkane compositions for use in the treatment of keratoconjunctivitis sicca |
| KR101874219B1 (en) | 2012-09-12 | 2018-07-03 | 노바리크 게엠베하 | Compositions comprising mixtures of semifluorinated alkanes |
| ES2743502T3 (en) * | 2015-09-30 | 2020-02-19 | Novaliq Gmbh | Semi-fluorinated compounds and their compositions |
| CN116172987A (en) * | 2016-09-22 | 2023-05-30 | 诺瓦利克有限责任公司 | Pharmaceutical composition for treating blepharitis |
| US11896559B2 (en) * | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
-
2019
- 2019-09-20 EP EP19786907.6A patent/EP3852734A1/en active Pending
- 2019-09-20 CN CN201980062052.2A patent/CN112739335A/en active Pending
- 2019-09-20 US US17/278,585 patent/US20210346313A1/en active Pending
- 2019-09-20 SG SG11202102818YA patent/SG11202102818YA/en unknown
- 2019-09-20 KR KR1020217011860A patent/KR20210080388A/en active Pending
- 2019-09-20 AU AU2019342426A patent/AU2019342426A1/en active Pending
- 2019-09-20 JP JP2021514550A patent/JP2022500461A/en active Pending
- 2019-09-20 CA CA3111873A patent/CA3111873A1/en active Pending
- 2019-09-20 WO PCT/EP2019/075406 patent/WO2020058504A1/en active Application Filing
-
2021
- 2021-03-15 IL IL281516A patent/IL281516A/en unknown
- 2021-03-18 PH PH12021550621A patent/PH12021550621A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3852734A1 (en) | 2021-07-28 |
| PH12021550621A1 (en) | 2022-02-14 |
| IL281516A (en) | 2021-04-29 |
| CN112739335A (en) | 2021-04-30 |
| JP2022500461A (en) | 2022-01-04 |
| KR20210080388A (en) | 2021-06-30 |
| US20210346313A1 (en) | 2021-11-11 |
| CA3111873A1 (en) | 2020-03-26 |
| WO2020058504A1 (en) | 2020-03-26 |
| AU2019342426A1 (en) | 2021-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281516A (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
| IL281773A (en) | Ophthalmic composition for treatment of dry eye disease | |
| IL278178A (en) | Use of pilocarpine hydrochloride for the treatment of ocular conditions | |
| PL3399962T3 (en) | Ophthalmic composition for treatment of dry eye disease | |
| IL273531A (en) | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases | |
| IL284344A (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| IL277557A (en) | Sap and peptidomimetics for treatment of eye disease | |
| ZA202002991B (en) | Methods and compositions for assessing and treating intraocular diseases and disorders | |
| PT3413868T (en) | Ophthalmic composition for the use in the treatment of eye disorders related to alterations of the corneal conjunctival surface | |
| IL287831A (en) | Oxymetazoline compositions and methods for treating ocular disorders | |
| EP3618868A4 (en) | Methods and compositions for treating allergic ocular diseases | |
| EP3644966A4 (en) | Treatment and diagnosis of ocular surface disorders | |
| EP3538083A4 (en) | Formulations for the treatment of ocular surface diseases and related methods | |
| EP3691654A4 (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| PT4031117T (en) | Agent for use in treatment or prevention of ophthalmic disorders | |
| ZA202003944B (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| SG11202012473UA (en) | Ophthalmic compositions and methods for the treatment of eye disorders | |
| ES3012007T3 (en) | Lipid-based ophthalmic composition for the treatment of dry eye | |
| IL287441A (en) | Compositions and methods useable for treatment of dry eye | |
| ZA202107235B (en) | Compositions and methods for treating ocular disease | |
| IL282898A (en) | Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases | |
| ZA202100656B (en) | Ophthalmic compositions and methods for the treatment of eye disorders and skin diseases | |
| SMT202300093T1 (en) | Nutraceutical ophthalmic composition for treating diseases of the retina with neovascular component | |
| RS65722B1 (en) | Ophthalmic composition for the treatment of dry eye disease | |
| EP3970751C0 (en) | Ophthalmic composition for the treatment of corneal edema |